WallStSmart
RLAY

Relay Therapeutics Inc

NASDAQ: RLAY · HEALTHCARE · BIOTECHNOLOGY

$12.57
-3.53% today

Updated 2026-04-29

Market cap
$2.41B
P/E ratio
P/S ratio
156.64x
EPS (TTM)
$-1.61
Dividend yield
52W range
$3 – $17
Volume
3.0M

Relay Therapeutics Inc (RLAY) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+18.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+28.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.7%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+11.3%
2026-02-26
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-26$-0.32+22.2%$9.22$10.26+11.3%
2025-11-06$-0.43-2.4%$6.55$6.05-7.6%
2025-08-07$-0.41+16.3%$3.53$3.22-8.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.41$-0.32+22.2%$7.00M
2025-09-30$-0.42$-0.43-2.4%
2025-06-30$-0.49$-0.41+16.3%$677000.00
2025-03-31$-0.71$-0.46+35.9%$7.68M-23.3%
2024-12-31$-0.55$-0.45+17.9%
2024-09-30$-0.77$-0.63+18.2%
2024-06-30$-0.73$-0.69+5.5%
2024-03-31$-0.70$-0.62+11.4%$10.01M
2023-12-31$-0.73$-0.67+8.2%$-1000.00
2023-09-30$-0.83$-0.54+34.9%$25.20M
2023-06-30$-0.82$-0.81+1.2%$119000.00

Frequently asked questions

Has Relay Therapeutics Inc beaten earnings estimates?
Relay Therapeutics Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +18.0% over the last 4 quarters.
How does RLAY stock react to earnings?
RLAY stock has moved an average of -1.7% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.